Dr. Yiu-Lian Fong is a BTC Committee member of Executive Yuan in Taiwan. She is a distinguished biotech R&D leader and has held significant senior leadership positions in many large global biotechnology and pharmaceutical companies, including Global Head of R&D for Diagnostic Innovation and CLIA Lab Operations at Janssen, J&J; Division Vice President of R&D at Abbott; and Executive Director of R&D for Novartis Oncology at Novartis. With ~30 years of rich experience in innovative drug development, blood screening, and in vitro diagnostics (IVD) development, she has made an unparalleled contribution to the field.
In this seminar, Dr. Fong will provide an important overview of global trends, key challenges, and potential opportunities in drug R&D, as well as the key enabling technologies that could potentially accelerate or facilitate drug development. Professionals from academia, industry, and research sectors who are engaged or interested in this subject are welcome to register and attend.
Time: 10:00, Aug 29, 2024(Thursday) (Registration will start at 09:30)
Venue: C212 Lecture Room, 2nd floor, Building C, National Biotechnology Research Park (Address: No. 99, Aly 130, Sec. 1, Academia Rd.,
Nangang District, Taipei City, Taiwan)
Title: Challenges and Opportunities in Drug Discovery and Development-Potential Enabling Technologies and the Outlook
Speaker: Yiu-Lian Fong, PhD, MBA Senior Scientific Advisor/Senior Corporate Strategy Advisor, MiRXES
Host: Dr. Han-Chung Wu Director/Biomedical Translation Research Center, Academia Sinica
Organizer: Biomedical Translation Research Center, Academia Sinica
Registration website: https://forms.gle/UQuh5hFGCH3xqQjJ9
Transportation information: https://nbrp.sinica.edu.tw/pages/41
Fee: Free of charge
Contact: Joyce Yuan
E-mail: joycepyy@gate.sinica.edu.tw
Tel: (02) 7750-5500 ext. 1523
